Mechanisms in bradykinin stimulated arachidonate release and synthesis of prostaglandin and platelet activating factor

D. Ricupero, L. Taylor, A. Tlucko, P. Polgar, Javier Navarro

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Regulatory mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) in the binding of BK to the cells was determined. Guanosine 5′-0-(thiotriphosphate), (GTPτS), lowered the binding affinity for BK and increased the Kd for the binding from 0.45 to 1.99 nM. The Bmax remained unaltered at 2.25 × 10 −11 mole. Exposure of the cells to aluminium fluoride also reduced the affinity for BK. Bradykinin-induced release of ARA proved pertussis toxin (PTX) sensitive, with a maximum sensitivity at 10 ug/ml PTX. GTPτS at 100 μM increased the release of arachidonate. The effect of GTPτS and BK was additive at suboptimal doses of BK up to 0.5 nM but never exceeded the levels of maximal BK stimulation at 50 nM. PTX also inhibited the release of ARA induced by the calcium ionophore, A23187. Phorbol 12-myristate 13-acetate or more commonly known as tetradecanoyl phorbol acetate (TPA) itself had little effect on release by the intact cells. However, at 100 nM it augmented the BK activated release. This was down-regulated by overnight exposure to TPA and correlated with down-regulation of protein kinase C (PKC) activity. The down-regulation only affected the augmentation of ARA release by TPA but not the original BK activated release. TPA displayed a similar, but more potent amplification of PAF synthesis in response to both BK or the calcium ionophore A23187. These results taken together point to the participation of G-protein in the binding of BK to BPAEC and its activation of ARA release. Possibly two types of G-protein are involved, one associated with the receptor, the other activated by Ca2+ and perhaps associated with phospholipase A2 (PLA2). Our results further suggest that a separate route of activation, probably also PLA2 related, takes place through a PKC catalysed phosphorylation.

Original languageEnglish (US)
Pages (from-to)133-140
Number of pages8
JournalMediators of Inflammation
Volume1
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Platelet Activating Factor
Bradykinin
Prostaglandins
Acetates
Pertussis Toxin
GTP-Binding Proteins
Calcium Ionophores
Phospholipases A2
Calcimycin
Protein Binding
Protein Kinase C
Pulmonary Artery
Down-Regulation
Endothelial Cells
Guanosine
Phosphorylation

Keywords

  • Arachidonate
  • Bradykinin
  • G-protein
  • Platelet activating factor
  • Prostaglandin synthesis

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Mechanisms in bradykinin stimulated arachidonate release and synthesis of prostaglandin and platelet activating factor. / Ricupero, D.; Taylor, L.; Tlucko, A.; Polgar, P.; Navarro, Javier.

In: Mediators of Inflammation, Vol. 1, No. 2, 1992, p. 133-140.

Research output: Contribution to journalArticle

@article{657887a08fdb4dcf8312b4cf70ba9f75,
title = "Mechanisms in bradykinin stimulated arachidonate release and synthesis of prostaglandin and platelet activating factor",
abstract = "Regulatory mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) in the binding of BK to the cells was determined. Guanosine 5′-0-(thiotriphosphate), (GTPτS), lowered the binding affinity for BK and increased the Kd for the binding from 0.45 to 1.99 nM. The Bmax remained unaltered at 2.25 × 10 −11 mole. Exposure of the cells to aluminium fluoride also reduced the affinity for BK. Bradykinin-induced release of ARA proved pertussis toxin (PTX) sensitive, with a maximum sensitivity at 10 ug/ml PTX. GTPτS at 100 μM increased the release of arachidonate. The effect of GTPτS and BK was additive at suboptimal doses of BK up to 0.5 nM but never exceeded the levels of maximal BK stimulation at 50 nM. PTX also inhibited the release of ARA induced by the calcium ionophore, A23187. Phorbol 12-myristate 13-acetate or more commonly known as tetradecanoyl phorbol acetate (TPA) itself had little effect on release by the intact cells. However, at 100 nM it augmented the BK activated release. This was down-regulated by overnight exposure to TPA and correlated with down-regulation of protein kinase C (PKC) activity. The down-regulation only affected the augmentation of ARA release by TPA but not the original BK activated release. TPA displayed a similar, but more potent amplification of PAF synthesis in response to both BK or the calcium ionophore A23187. These results taken together point to the participation of G-protein in the binding of BK to BPAEC and its activation of ARA release. Possibly two types of G-protein are involved, one associated with the receptor, the other activated by Ca2+ and perhaps associated with phospholipase A2 (PLA2). Our results further suggest that a separate route of activation, probably also PLA2 related, takes place through a PKC catalysed phosphorylation.",
keywords = "Arachidonate, Bradykinin, G-protein, Platelet activating factor, Prostaglandin synthesis",
author = "D. Ricupero and L. Taylor and A. Tlucko and P. Polgar and Javier Navarro",
year = "1992",
doi = "10.1155/S096293519200022X",
language = "English (US)",
volume = "1",
pages = "133--140",
journal = "Mediators of Inflammation",
issn = "0962-9351",
publisher = "Hindawi Publishing Corporation",
number = "2",

}

TY - JOUR

T1 - Mechanisms in bradykinin stimulated arachidonate release and synthesis of prostaglandin and platelet activating factor

AU - Ricupero, D.

AU - Taylor, L.

AU - Tlucko, A.

AU - Polgar, P.

AU - Navarro, Javier

PY - 1992

Y1 - 1992

N2 - Regulatory mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) in the binding of BK to the cells was determined. Guanosine 5′-0-(thiotriphosphate), (GTPτS), lowered the binding affinity for BK and increased the Kd for the binding from 0.45 to 1.99 nM. The Bmax remained unaltered at 2.25 × 10 −11 mole. Exposure of the cells to aluminium fluoride also reduced the affinity for BK. Bradykinin-induced release of ARA proved pertussis toxin (PTX) sensitive, with a maximum sensitivity at 10 ug/ml PTX. GTPτS at 100 μM increased the release of arachidonate. The effect of GTPτS and BK was additive at suboptimal doses of BK up to 0.5 nM but never exceeded the levels of maximal BK stimulation at 50 nM. PTX also inhibited the release of ARA induced by the calcium ionophore, A23187. Phorbol 12-myristate 13-acetate or more commonly known as tetradecanoyl phorbol acetate (TPA) itself had little effect on release by the intact cells. However, at 100 nM it augmented the BK activated release. This was down-regulated by overnight exposure to TPA and correlated with down-regulation of protein kinase C (PKC) activity. The down-regulation only affected the augmentation of ARA release by TPA but not the original BK activated release. TPA displayed a similar, but more potent amplification of PAF synthesis in response to both BK or the calcium ionophore A23187. These results taken together point to the participation of G-protein in the binding of BK to BPAEC and its activation of ARA release. Possibly two types of G-protein are involved, one associated with the receptor, the other activated by Ca2+ and perhaps associated with phospholipase A2 (PLA2). Our results further suggest that a separate route of activation, probably also PLA2 related, takes place through a PKC catalysed phosphorylation.

AB - Regulatory mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) in the binding of BK to the cells was determined. Guanosine 5′-0-(thiotriphosphate), (GTPτS), lowered the binding affinity for BK and increased the Kd for the binding from 0.45 to 1.99 nM. The Bmax remained unaltered at 2.25 × 10 −11 mole. Exposure of the cells to aluminium fluoride also reduced the affinity for BK. Bradykinin-induced release of ARA proved pertussis toxin (PTX) sensitive, with a maximum sensitivity at 10 ug/ml PTX. GTPτS at 100 μM increased the release of arachidonate. The effect of GTPτS and BK was additive at suboptimal doses of BK up to 0.5 nM but never exceeded the levels of maximal BK stimulation at 50 nM. PTX also inhibited the release of ARA induced by the calcium ionophore, A23187. Phorbol 12-myristate 13-acetate or more commonly known as tetradecanoyl phorbol acetate (TPA) itself had little effect on release by the intact cells. However, at 100 nM it augmented the BK activated release. This was down-regulated by overnight exposure to TPA and correlated with down-regulation of protein kinase C (PKC) activity. The down-regulation only affected the augmentation of ARA release by TPA but not the original BK activated release. TPA displayed a similar, but more potent amplification of PAF synthesis in response to both BK or the calcium ionophore A23187. These results taken together point to the participation of G-protein in the binding of BK to BPAEC and its activation of ARA release. Possibly two types of G-protein are involved, one associated with the receptor, the other activated by Ca2+ and perhaps associated with phospholipase A2 (PLA2). Our results further suggest that a separate route of activation, probably also PLA2 related, takes place through a PKC catalysed phosphorylation.

KW - Arachidonate

KW - Bradykinin

KW - G-protein

KW - Platelet activating factor

KW - Prostaglandin synthesis

UR - http://www.scopus.com/inward/record.url?scp=0011565504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0011565504&partnerID=8YFLogxK

U2 - 10.1155/S096293519200022X

DO - 10.1155/S096293519200022X

M3 - Article

VL - 1

SP - 133

EP - 140

JO - Mediators of Inflammation

JF - Mediators of Inflammation

SN - 0962-9351

IS - 2

ER -